BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11224748)

  • 1. Positron emission tomography in urological malignancy.
    Brush JP
    Curr Opin Urol; 2001 Mar; 11(2):175-9. PubMed ID: 11224748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography in uro-oncology.
    Hain SF
    Cancer Imaging; 2005 Jan; 5(1):1-7. PubMed ID: 16154810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron-emission tomography imaging in urological oncology: Current aspects and developments.
    Rauscher I; Eiber M; Weber WA; Gschwend JE; Horn T; Maurer T
    Int J Urol; 2018 Nov; 25(11):912-921. PubMed ID: 30103285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
    [No Abstract]   [Full Text] [Related]  

  • 5. Positron emission tomography for urological tumours.
    Hain SF; Maisey MN
    BJU Int; 2003 Jul; 92(2):159-64. PubMed ID: 12823366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.
    Bouchelouche K; Oehr P
    J Urol; 2008 Jan; 179(1):34-45. PubMed ID: 17997425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography in urologic oncology.
    Shvarts O; Han KR; Seltzer M; Pantuck AJ; Belldegrun AS
    Cancer Control; 2002; 9(4):335-42. PubMed ID: 12228759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of FDG-PET in the evaluation of urologic malignancies.
    Bender H; Schomburg A; Albers P; Ruhlmann J; Biersack HJ
    Anticancer Res; 1997; 17(3B):1655-60. PubMed ID: 9179213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and monitoring of urological tumors using positron emission tomography.
    Hofer C; Kübler H; Hartung R; Breul J; Avril N
    Eur Urol; 2001 Nov; 40(5):481-7. PubMed ID: 11752853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Accuracy of computed tomography in urological tumour diagnosis (author's transl)].
    Latal D; Kuber W; Imhof H; Küster W
    Wien Klin Wochenschr; 1981 Jun; 93(13):415-20. PubMed ID: 7269622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography in urologic patients: preliminary assessment.
    Riehle RA; McCarron JP; Kazam E; Muecke EC
    Urology; 1977 Dec; 10(6):529-35. PubMed ID: 601931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of positron emission tomography and computer tomography (PET/CT) for urologic malignancies].
    Boujelbene N; Prior JO; Boubaker A; Azria D; Schaffer M; Gez E; Jichlinski P; Meuwly JY; Mirimanoff RO; Ozsahin M; Zouhair A
    Cancer Radiother; 2011 Jul; 15(4):307-15. PubMed ID: 21507695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on advances in molecular PET in urological oncology.
    Kitajima K; Yamamoto S; Fukushima K; Minamimoto R; Kamai T; Jadvar H
    Jpn J Radiol; 2016 Jul; 34(7):470-85. PubMed ID: 27222021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography in urological oncology.
    Hoh CK; Seltzer MA; Franklin J; deKernion JB; Phelps ME; Belldegrun A
    J Urol; 1998 Feb; 159(2):347-56. PubMed ID: 9649238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers.
    Greco F; Cadeddu JA; Gill IS; Kaouk JH; Remzi M; Thompson RH; van Leeuwen FW; van der Poel HG; Fornara P; Rassweiler J
    Eur Urol; 2014 May; 65(5):947-64. PubMed ID: 23957947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of computer tomography in staging urological tumors before radical surgery].
    Romics I; Will C; Beutler W; Bach D
    Orv Hetil; 1991 Dec; 132(50):2779-81. PubMed ID: 1823099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of the indication for lymphangiography in urological tumor patients (author's transl)].
    Rübben H; Lutzeyer W
    Urologe A; 1981 Jan; 20(1):31-7. PubMed ID: 7013234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG in Urologic Malignancies.
    Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
    PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic imaging in cancer therapy: the genito-urinary system].
    Ishikawa N; Tatezawa T; Ishikawa S; Hiramatsu Y
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):197-203. PubMed ID: 7184396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.